These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. [Anticoagulant treatment of arterial diseases of the extremities]. FRILEUX C; SAKKA M Gaz Med Fr; 1958 Sep; 65(17):1355-6 passim. PubMed ID: 13586557 [No Abstract] [Full Text] [Related]
45. [Experiences with Sintroma "Geigy" as an anticoagulant, especially in the long-term treatment of peripheral arterial obliteration]. EJRUP B Sven Lakartidn; 1961 Feb; 58():257-74 passim. PubMed ID: 13726231 [No Abstract] [Full Text] [Related]
46. [Nicotinamide hydroiodide in the treatment of degenerative arterial diseases]. GUAGLIANO G; STOPPANI L Minerva Med; 1957 Oct; 48(85):3544-8. PubMed ID: 13493209 [No Abstract] [Full Text] [Related]
47. [Arteriovenous fistula in the picture of chronic juvenile obliterating arterial disease]. CADILI G Minerva Chir; 1956 Nov; 11(22):1121-31. PubMed ID: 13399836 [No Abstract] [Full Text] [Related]
48. [Experience with surgical treatment of chronic obliterating peripheral arteriopathies]. VINK M Ned Tijdschr Geneeskd; 1954 Apr; 98(16):1057-63. PubMed ID: 13165820 [No Abstract] [Full Text] [Related]
49. [Experiences with Sintroma "Geigy" as an anticoagulant used mainly in the long-term treatment of peripheral arterial obliterations. II. The therapeutic effects of long-term treatment]. EJRUP B Sven Lakartidn; 1961 Feb; 58():426-41. PubMed ID: 13726230 [No Abstract] [Full Text] [Related]
50. [Treatment of disease causing decrease in the lumen of peripheral blood vessels by intra-arterial oxygen administration]. SADLINSKI C; MADEJSKI T Pol Tyg Lek (Wars); 1959 Feb; 14(6):245-9. PubMed ID: 13667551 [No Abstract] [Full Text] [Related]
51. [Rational methods of treatment of obliterating diseases of the peripheral vessels in ambulatory conditions]. LIDSKII AT Khirurgiia (Mosk); 1961 May; 37():3-7. PubMed ID: 13761960 [No Abstract] [Full Text] [Related]
52. [Diagnostic considerations on peripheral obliterating arterial diseases]. GJERTZ A Sven Lakartidn; 1953 Oct; 50(44):2249-60. PubMed ID: 13122545 [No Abstract] [Full Text] [Related]
53. [Apparatus for the treatment of peripheral circulatory disorders by means of arterial high pressure infusion]. BRANDT H Dtsch Gesundheitsw; 1955 Apr; 10(15):555-7. PubMed ID: 14379831 [No Abstract] [Full Text] [Related]
55. [Tentative interpretation of the mechanism of action of heparin in small dosage by intra-arterial route in various peripheral vascular diseases]. BUTTO' M; MASETTO I; MENOZZI L Riforma Med; 1955 Jan; 69(3):61-5. PubMed ID: 14372779 [No Abstract] [Full Text] [Related]
56. [Syndrome of acute arterial occlusion, Its treatment]. GURRUCHAGA JV An Cir (Rosario); 1960; 25():103-8. PubMed ID: 13709887 [No Abstract] [Full Text] [Related]
57. [Peripheral arterial disease: where are we in 2006?]. Sraieb T; Bougamra S; Ben Romdhane N; Longo S; Manaa J Tunis Med; 2007 May; 85(5):361-6. PubMed ID: 17657918 [TBL] [Abstract][Full Text] [Related]